儿童股骨近端肿瘤切除后髋关节置换:年龄与关节类型对假体生存及髋臼翻修结局的影响
这项单中心回顾性队列研究分析了60例2至16岁因恶性骨肿瘤行股骨近端假体置换联合半髋或全髋关节置换的患者。青春期前患者无翻修生存率较差,青春期患者行全髋关节置换较半髋关节置换的无翻修假体生存率更优,但全髋关节置换可能带来早期术后脱位风险。半髋关节置换失败后翻修为全髋关节置换的假体生存良好。
要点
- 青春期前患者(≤12岁)无论关节类型,无翻修生存率均较差(5年54%,10年21%)。
- 青春期患者(>12岁)行全髋关节置换的无翻修假体生存优于半髋关节置换(P=0.048)。
- 半髋关节置换后失败模式因年龄而异:青春期前以半脱位为主,青春期以软骨溶解为主。
核心结论
- 非常年轻的患者在股骨近端假体置换后第一个十年内再手术风险高。
- 青春期患者行全髋关节置换联合股骨近端假体置换较半髋关节置换可改善无翻修假体生存,但可能引入早期术后脱位风险。
- 半髋关节置换失败后翻修为全髋关节置换的假体生存耐久。
研究设计与样本
- 回顾性单中心队列研究,纳入1982年1月至2023年4月间60例2至16岁行恶性骨肿瘤切除及股骨近端假体置换联合半髋或全髋关节置换的患者,中位随访12.6年(IQR 4至21)。
主要发现
- 共41例半髋关节置换和19例全髋关节置换。
- 青春期前患者(≤12岁)无翻修生存率5年为54%(95%CI 38至77),10年为21%(95%CI 8至54)。
- 青春期患者(>12岁)行全髋关节置换(n=12)的中位、5年及10年无翻修假体生存分别为21.9年(IQR 11.9至22.7)、89%(95%CI 71至100)和78%(95%CI 55至100)。
- 青春期患者行半髋关节置换(n=15)的中位、5年及10年无翻修假体生存分别为7.1年(IQR 4.9至13.5)、68%(95%CI 46至100)和39%(95%CI 18至82),与全髋关节置换比较P=0.048。
- 所有年龄组翻修的主要指征为髋臼并发症;半髋关节半脱位仅见于青春期前队列(14/26),中位时间2.8年(IQR 2至8);软骨溶解见于青春期队列(8/27),中位时间7.1年(IQR 2至12)。
临床怎么用
- 对于青春期前儿童股骨近端肿瘤切除后行股骨近端假体置换,应预期较高的再手术风险。
- 青春期患者可考虑全髋关节置换联合股骨近端假体置换以改善假体生存,但需警惕早期脱位风险。
- 半髋关节置换失败后翻修为全髋关节置换是耐久的选择。
局限性
- 回顾性单中心设计,样本量较小(60例),随访时间跨度大,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Hip arthroplasty is rarely required before skeletal maturity. However, it is appropriate after resection of a proximal femoral bone tumour. This retrospective single-centre cohort study was conducted to evaluate how age and choice of articulation affects modes of implant failure and revision-free survival, and to understand the longer-term outcomes following inevitable revision. METHODS: Between January 1982 and April 2023, 60 patients aged between two and 16 years underwent excision of a malignant bone tumour and proximal femoral endoprosthetic reconstruction (PFEPR) combined with either a hemiarthroplasty (HA) or total hip arthroplasty (THA) articulation. The median follow-up was 12.6 years (IQR 4 to 21). RESULTS: There were 41 HAs and 19 THAs. Revision-free survival was poor in pre-adolescent patients (age ≤ 12 years) regardless of articulation (54% at five years (95% CI 38 to 77) and 21% at ten years (95% CI 8 to 54)). Adolescent patients (age > 12 years) undergoing THA (n = 12) had better median, five-year, and ten-year revision-free implant survival (21.9 years (IQR 11.9 to 22.7), 89% (95% CI 71 to 100), and 78% (55 to 100), respectively) than similarly aged patients undergoing HA (n = 15); (7.1 years (IQR 4.9 to 13.5), 68% (95% CI 46 to 100), 39% (18 to 82); p = 0.048), respectively). The leading indication for revision across all ages was an acetabular complication. HA subluxation occurred exclusively in the pre-adolescent cohort (14/26) at a median 2.8 years (IQR 2 to 8). Chondrolysis occurred in the adolescent cohort (8/27) at a median 7.1 years (IQR 2 to 12). Revision THA after failed HA (n = 35) survived well (85% (95% CI 71 to 100) and 77% (60 to 100) at five and ten years) although an early postoperative dislocation rate of 12% (n = 4) was observed, all of which were managed by closed reduction. CONCLUSION: Very young patients continue have a high risk of further surgery in the first decade after PFEPR. THA combined with PFEPR appears to improve revision-free implant survival in adolescent patients when compared with HA; however, it may introduce a risk of early postoperative dislocation. Following HA, there is a different mode of failure in pre-adolescent compared with adolescent patients, and revision to THA in either circumstance is durable.
引用
- Baird CAE, Green N, Evans S, et al. Hip arthroplasty following proximal femoral tumour resection in children : the impact of age and articulation on implant survival and the outcomes following acetabular revision. Bone Joint J. 2026. PMID: 42674576. doi:10.1302/0301-620X.108B9.BJJ-2025-1473.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。